Nivolumab/relatlimab-associated cutaneous immune-related adverse events in patients treated for advanced melanoma: Supplemental file
收藏Mendeley Data2026-04-09 收录
下载链接：
https://data.mendeley.com/datasets/jvw7f27cch
下载链接
链接失效反馈官方服务：
资源简介：
Supplementary tables I (multivariable analysis of patient characteristics associated with developing cirAEs on nivolumab-relatlimab) and II (choice of therapy for the management of first, second, and third cirAEs)
提供机构：
Harvard Medical School; Massachusetts General Hospital; Massachusetts General Hospital Cancer Center; Brigham and Women's Hospital
